Cargando…

Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?

Mitochondrial dysfunction is a hallmark of Parkinson’s disease (PD). Astrocytes are the most abundant glial cell type in the brain and are thought to play a pivotal role in the progression of PD. Emerging evidence suggests that many astrocytic functions, including glutamate metabolism, Ca(2+) signal...

Descripción completa

Detalles Bibliográficos
Autores principales: Bantle, Collin M., Hirst, Warren D., Weihofen, Andreas, Shlevkov, Evgeny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849831/
https://www.ncbi.nlm.nih.gov/pubmed/33537300
http://dx.doi.org/10.3389/fcell.2020.608026
_version_ 1783645362614960128
author Bantle, Collin M.
Hirst, Warren D.
Weihofen, Andreas
Shlevkov, Evgeny
author_facet Bantle, Collin M.
Hirst, Warren D.
Weihofen, Andreas
Shlevkov, Evgeny
author_sort Bantle, Collin M.
collection PubMed
description Mitochondrial dysfunction is a hallmark of Parkinson’s disease (PD). Astrocytes are the most abundant glial cell type in the brain and are thought to play a pivotal role in the progression of PD. Emerging evidence suggests that many astrocytic functions, including glutamate metabolism, Ca(2+) signaling, fatty acid metabolism, antioxidant production, and inflammation are dependent on healthy mitochondria. Here, we review how mitochondrial dysfunction impacts astrocytes, highlighting translational gaps and opening new questions for therapeutic development.
format Online
Article
Text
id pubmed-7849831
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78498312021-02-02 Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease? Bantle, Collin M. Hirst, Warren D. Weihofen, Andreas Shlevkov, Evgeny Front Cell Dev Biol Cell and Developmental Biology Mitochondrial dysfunction is a hallmark of Parkinson’s disease (PD). Astrocytes are the most abundant glial cell type in the brain and are thought to play a pivotal role in the progression of PD. Emerging evidence suggests that many astrocytic functions, including glutamate metabolism, Ca(2+) signaling, fatty acid metabolism, antioxidant production, and inflammation are dependent on healthy mitochondria. Here, we review how mitochondrial dysfunction impacts astrocytes, highlighting translational gaps and opening new questions for therapeutic development. Frontiers Media S.A. 2021-01-07 /pmc/articles/PMC7849831/ /pubmed/33537300 http://dx.doi.org/10.3389/fcell.2020.608026 Text en Copyright © 2021 Bantle, Hirst, Weihofen and Shlevkov. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Bantle, Collin M.
Hirst, Warren D.
Weihofen, Andreas
Shlevkov, Evgeny
Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?
title Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?
title_full Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?
title_fullStr Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?
title_full_unstemmed Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?
title_short Mitochondrial Dysfunction in Astrocytes: A Role in Parkinson’s Disease?
title_sort mitochondrial dysfunction in astrocytes: a role in parkinson’s disease?
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849831/
https://www.ncbi.nlm.nih.gov/pubmed/33537300
http://dx.doi.org/10.3389/fcell.2020.608026
work_keys_str_mv AT bantlecollinm mitochondrialdysfunctioninastrocytesaroleinparkinsonsdisease
AT hirstwarrend mitochondrialdysfunctioninastrocytesaroleinparkinsonsdisease
AT weihofenandreas mitochondrialdysfunctioninastrocytesaroleinparkinsonsdisease
AT shlevkovevgeny mitochondrialdysfunctioninastrocytesaroleinparkinsonsdisease